PHP
KNSA icon

Parkman Healthcare Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Parkman Healthcare Partners’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-259,184
Closed -$12.5M – 91
2026
Q1 		$12.5M Sell
259,184
-406,024
-61% -$18M 1.29% 26
2025
Q4 		$27.4M Sell
665,208
-6,384
-1% -$256K 2.61% 9
2025
Q3 		$26.1M Buy
671,592
+182,796
+37% +$5.94M 2.72% 6
2025
Q2 		$13.5M Sell
488,796
-273,825
-36% -$6.97M 1.55% 21
2025
Q1 		$16.9M Sell
762,621
-2,832
-0.4% -$58.3K 2.01% 16
2024
Q4 		$15.1M Buy
765,453
+10,209
+1% +$233K 2.02% 16
2024
Q3 		$18.9M Buy
755,244
+108,102
+17% +$2.63M 2.41% 9
2024
Q2 		$12.1M Buy
647,142
+979
+0.2% +$18.3K 1.62% 21
2024
Q1 		$12.7M Buy
646,163
+30,470
+5% +$595K 1.56% 20
2023
Q4 		$10.8M Buy
615,693
+105,883
+21% +$1.74M 1.52% 21
2023
Q3 		$8.86M Buy
509,810
+218,107
+75% +$3.67M 1.62% 16
2023
Q2 		$4.11M Buy
291,703
+41,446
+17% +$555K 0.71% 44
2023
Q1 		$2.69M Buy
250,257
+58,950
+31% +$777K 0.59% 50
2022
Q4 		$2.87M Buy
191,307
+65,115
+52% +$948K 0.76% 47
2022
Q3 		$1.62M Buy
126,192
+1,484
+1% +$16.9K 0.46% 64
2022
Q2 		$1.21M Buy
124,708
+6,461
+5% +$60.3K 0.44% 56
2022
Q1 		$1.18M Buy
118,247
+4,603
+4% +$48.8K 0.34% 64
2021
Q4 		$1.34M Buy
+113,644
New +$1.4M 0.3% 68
2021
Q2 		– Sell
-80,603
Closed -$1.49M – 91
2021
Q1 		$1.49M Buy
80,603
+5,603
+7% +$115K 0.35% 66
2020
Q4 		$1.32M Buy
+75,000
New +$1.32M 0.34% 70

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Parkman Healthcare Partners's KNSA Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2026, closing a stake of 259,184 shares — an estimated $12.5M sold.

Parkman Healthcare Partners first reported a position in KNSA in Q4 2020 and held it in 20 quarters. The position peaked at $27.4M in Q4 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Kiniksa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 259,184 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $12.5M.
  • Parkman Healthcare Partners first reported a position in Kiniksa Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Parkman Healthcare Partners's Kiniksa Pharmaceuticals position peaked at $27.4M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.